Formulation, Characterization, Antioxidant, Cytotoxicity, and Antiprostate Cancer Efficacies of Plant-Based Nanoparticles

IF 3.7 2区化学 Q2 CHEMISTRY, APPLIED

Applied Organometallic Chemistry Pub Date : 2025-09-25 DOI:10.1002/aoc.70353

Zehui Rao, Zhangjie Jiang, Chengyu Zou, Yida Zhang

{"title":"Formulation, Characterization, Antioxidant, Cytotoxicity, and Antiprostate Cancer Efficacies of Plant-Based Nanoparticles","authors":"Zehui Rao, Zhangjie Jiang, Chengyu Zou, Yida Zhang","doi":"10.1002/aoc.70353","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Here, we show how <i>Boswellia thurifera</i> extract may be used to bio-inspiredly synthesize zinc nanoparticles. <i>B. thurifera</i> was employed as an environmentally friendly medium that served as both an in situ stabilizer and a green reductant for the produced zinc nanoparticles. The intrinsic structural characteristics of the as-synthesized Zn NPs were studied by FE-SEM, EDX, XRD, and UV–Vis. Prostate cancer cell lines were used to evaluate the biogenic Zn NPs' antiprostate cancer capabilities. The MTT experiment showed that the Zn NPs could strongly inhibit the proliferation of LNCaP clone FGC-Luc2 cancer cells. In contrast to their corresponding control, Zn NPs prevent colony development. More importantly, the cells molecular pathway analysis treated with zinc nanoparticles showed that the extract increases the expression of p53 while suppressing the expression of STAT3 in cells. This suggests that STAT3 and p53 are the primary players responsible for the biological events that the extract triggers in human prostate cancer cells. Our data suggest that zinc nanoparticles might be a very promising anticancer drug against human prostate cancer cells.</p>\n </div>","PeriodicalId":8344,"journal":{"name":"Applied Organometallic Chemistry","volume":"39 10","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Organometallic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/aoc.70353","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}

引用次数: 0

Abstract

Here, we show how Boswellia thurifera extract may be used to bio-inspiredly synthesize zinc nanoparticles. B. thurifera was employed as an environmentally friendly medium that served as both an in situ stabilizer and a green reductant for the produced zinc nanoparticles. The intrinsic structural characteristics of the as-synthesized Zn NPs were studied by FE-SEM, EDX, XRD, and UV–Vis. Prostate cancer cell lines were used to evaluate the biogenic Zn NPs' antiprostate cancer capabilities. The MTT experiment showed that the Zn NPs could strongly inhibit the proliferation of LNCaP clone FGC-Luc2 cancer cells. In contrast to their corresponding control, Zn NPs prevent colony development. More importantly, the cells molecular pathway analysis treated with zinc nanoparticles showed that the extract increases the expression of p53 while suppressing the expression of STAT3 in cells. This suggests that STAT3 and p53 are the primary players responsible for the biological events that the extract triggers in human prostate cancer cells. Our data suggest that zinc nanoparticles might be a very promising anticancer drug against human prostate cancer cells.

Abstract Image

查看原文本刊更多论文

植物基纳米颗粒的配方、表征、抗氧化、细胞毒性和抗前列腺癌功效

在这里，我们展示了如何将乳香草提取物用于生物启发合成锌纳米颗粒。thurifera是一种环境友好型培养基，可作为锌纳米颗粒的原位稳定剂和绿色还原剂。采用FE-SEM、EDX、XRD、UV-Vis等手段研究了锌纳米粒子的内在结构特征。用前列腺癌细胞系评价生物源性锌NPs的抗前列腺癌能力。MTT实验表明，Zn NPs对LNCaP克隆FGC-Luc2癌细胞的增殖有较强的抑制作用。与相应的对照相比，锌NPs可以阻止菌落的发育。更重要的是，锌纳米颗粒处理的细胞分子通路分析显示，提取物增加了p53的表达，抑制了细胞中STAT3的表达。这表明STAT3和p53是该提取物在人类前列腺癌细胞中引发的生物事件的主要参与者。我们的数据表明，锌纳米颗粒可能是一种非常有前途的抗癌药物，可以对抗人类前列腺癌细胞。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Applied Organometallic Chemistry 化学-无机化学与核化学

CiteScore

7.80

自引率

10.30%

发文量

408

审稿时长

2.2 months

期刊介绍： All new compounds should be satisfactorily identified and proof of their structure given according to generally accepted standards. Structural reports, such as papers exclusively dealing with synthesis and characterization, analytical techniques, or X-ray diffraction studies of metal-organic or organometallic compounds will not be considered. The editors reserve the right to refuse without peer review any manuscript that does not comply with the aims and scope of the journal. Applied Organometallic Chemistry publishes Full Papers, Reviews, Mini Reviews and Communications of scientific research in all areas of organometallic and metal-organic chemistry involving main group metals, transition metals, lanthanides and actinides. All contributions should contain an explicit application of novel compounds, for instance in materials science, nano science, catalysis, chemical vapour deposition, metal-mediated organic synthesis, polymers, bio-organometallics, metallo-therapy, metallo-diagnostics and medicine. Reviews of books covering aspects of the fields of focus are also published.